MGX
Metagenomi, Inc. Common Stock
NASDAQ: MGX · HEALTHCARE · BIOTECHNOLOGY
$1.38
+2.22% today
Updated 2026-04-30
Market cap
$55.68M
P/E ratio
—
P/S ratio
2.21x
EPS (TTM)
$-2.36
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Metagenomi, Inc. Common Stock (MGX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $24.26M | $29.72M | $-91.41M | $-109.07M | $-88.89M |
| Capital expenditures | $2.90M | $13.98M | $9.81M | $3.11M | $574000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $375000.00 | $1.96M | $6.92M | $16.20M | $11.85M |
| Free cash flow | $21.35M | $15.75M | $-101.22M | $-112.19M | $-89.47M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |